Typhoid Vaccine Studies X-The Suitability of Vi Antigen as an Auxiliary Immunogen for Typhoid Vaccine.
作者信息
Luippold G F
出版信息
Am J Public Health Nations Health. 1946 Jan;36(1):15-25.
Abstract
摘要
相似文献
1
Typhoid Vaccine Studies X-The Suitability of Vi Antigen as an Auxiliary Immunogen for Typhoid Vaccine.伤寒疫苗研究X - Vi抗原作为伤寒疫苗辅助免疫原的适用性
Am J Public Health Nations Health. 1946 Jan;36(1):15-25.
2
Typhoid vaccine studies; the suitability of Vi antigen as an auxiliary immunogen for typhoid vaccine; progress report.伤寒疫苗研究；Vi抗原作为伤寒疫苗辅助免疫原的适用性；进展报告。
Am J Public Health Nations Health. 1946 Jan;36:15-25.
3
Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.Vi 多糖伤寒疫苗经注射引起的针对非伤寒沙门氏菌的交叉免疫反应。
Vaccine. 2014 Jan 23;32(5):544-51. doi: 10.1016/j.vaccine.2013.12.001. Epub 2013 Dec 14.
4
Typhoid Vi: a less reactogenic vaccine.伤寒Vi疫苗：一种反应原性较低的疫苗。
J Int Med Res. 1992 Jun;20(3):247-53. doi: 10.1177/030006059202000306.
5
Development of a bivalent conjugate vaccine candidate against malaria transmission and typhoid fever.疟疾传播和伤寒双价结合疫苗候选物的研制。
Vaccine. 2018 May 17;36(21):2978-2984. doi: 10.1016/j.vaccine.2018.04.035. Epub 2018 Apr 20.
6
Comparison of safety and immunogenicity of a Vi polysaccharide typhoid vaccine with a whole-cell killed vaccine in Malaysian Air Force recruits.马来西亚空军新兵中Vi多糖伤寒疫苗与全细胞灭活疫苗的安全性和免疫原性比较。
Bull World Health Organ. 2001;79(9):811-7. Epub 2001 Oct 23.
7
Vaccines for preventing typhoid fever.预防伤寒热的疫苗。
Cochrane Database Syst Rev. 2014 Jan 2(1):CD001261. doi: 10.1002/14651858.CD001261.pub3.
8
An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine.1999年中华人民共和国兴安县伤寒热暴发：Vi多糖伤寒疫苗现场效果评估
J Infect Dis. 2001 Jun 15;183(12):1775-80. doi: 10.1086/320729. Epub 2001 May 17.
9
In vitro characterization and preclinical immunogenicity of Typhax, a typhoid fever protein capsular matrix vaccine candidate.体外鉴定和伤寒蛋白荚膜基质疫苗候选物 Typhax 的临床前免疫原性。
Hum Vaccin Immunother. 2019;15(6):1310-1316. doi: 10.1080/21645515.2019.1599674. Epub 2019 May 28.
10
Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.Vi-CRM197 结合疫苗在南亚和东南亚成人、儿童和婴儿中的免疫原性和安全性：两项随机、观察者盲法、年龄递减、2 期临床试验结果。
Lancet Infect Dis. 2014 Feb;14(2):119-29. doi: 10.1016/S1473-3099(13)70241-X. Epub 2013 Nov 28.
引用本文的文献
1
The pathogenic and immunogenic activities of Salmonella typhi in relation to its antigenic constituents.伤寒沙门氏菌的致病和免疫原性活性与其抗原成分的关系。
J Hyg (Lond). 1951 Mar;49(1):92-110. doi: 10.1017/s0022172400015394.
2
The preparation, testing and standardization of typhoid vaccine.伤寒疫苗的制备、检测与标准化
J Hyg (Lond). 1951 Jun-Sep;49(2-3):268-97. doi: 10.1017/s0022172400044156.
3
Studies on infection and immunity in experimental typhoid fever. III. Effect of prophylactic immunization.实验性伤寒热感染与免疫研究。III. 预防性免疫的效果。
J Exp Med. 1961 Sep 1;114(3):327-42. doi: 10.1084/jem.114.3.327.
本文引用的文献
1
A Proposed Typhoid Immunogenic Unit for Evaluation of Antityphoid Immunizing Substances.一种用于评估抗伤寒免疫物质的伤寒免疫原性单位的提议
Am J Public Health Nations Health. 1945 Feb;35(2):153-8. doi: 10.2105/ajph.35.2.153.
Zotero 插件